About admin

This author has not yet filled in any details.
So far admin has created 19 blog entries.

Metabolomic Diagnostics secures additional $2 million in venture funding

Metabolomic Diagnostics, has secured an additional €1.6 million in from investors to help complete PrePsia™, its new screening test for pre-eclampsia in first time pregnant mothers. This latest funding round is supported by existing investors, SOSventures, Enterprise Equity and Enterprise Ireland as well as a number [...]

Metabolomic Diagnostics Recruitment

Metabolomic Diagnostics have expanded its team by recruiting Paloma Muñiz Ortea and Leslie Brown. Ms. Muñiz Ortea is our R&D Product Development manager. Paloma is trained as an analytical chemist and holds a PhD from the Cork Institute of Technology where she developed analytical methods [...]

Preeclampsia Foundations’ Preeclampsia Awareness Month

As a nationally recognized health observance, Preeclampsia Awareness Month presents the perfect opportunity for the Preeclampsia Foundation to offer education and events that will increase awareness of this life-threatening hypertensive disorder of pregnancy, which occurs in up to eight percent of all pregnancies. The Preeclampsia [...]

Metabolomic Diagnostics to attend SRI 2016 in Montreal, Canada

Metabolomic Diagnostics’ Director of R&D, Dr. Robin Tuytten will attend the SRI’s 63rd Annual Scientific Meeting, which will take place at the Palais des congres de Montreal in Montreal, QC, Canada, from March 16 – 19, 2016. Prof. Louise Kenny of the Irish Centre for Fetal [...]

Dr. Robin Tuytten’s Webinar on Stratification For Pre-eclampsia

Yesterday afternoon, Metabolomic Diagnostics’ Director of R&D, Dr. Robin Tuytten, hosted a complimentary webinar on Stratification for Pre-eclampsia: Lessons Learned from Translation of a Metabolomics Discovery to a Robust LC-MS-20160229 1400-1. The event was hosted by the AACC and sponsored by Agilent Technologies. If you missed [...]

AACC Complimentary Webinar – Stratification For Pre-eclampsia

On February 29th, join Metabolomic Diagnostics’ Director of R&D, Dr. Robin Tuytten, for an informative look at what it takes to translate the results of an unbiased metabolomics discovery study into a robust analytical pipeline centered around a research-use-only, semi-quantitative LC-MS/MS methodology. Registration is complimentary. [...]

Mother Of Invention: Making Maternal Care Matter

Professor Louise Kenny, inventor of Metabolomic Diagnostics revolutionary technology recently spoke to the Health Independent about being a Mother, a Doctor, and an Innovator. The article is reproduced here: Maternal and perinatal disease account for 10 per cent of the global disease burden, yet only [...]

Metabolomic Diagnostics Research Team Wins Award At ISSHP Europe

At the recent International Society For The Study Of Hypertension in Pregnancy Congress in Budapest, Metabolomic Diagnostics submitted a Poster outlining the team’s ongoing Mass Spec Research. We were delighted when our research was recognised by the organising committee with an award as one of [...]

Metabolomic Diagnostics Recruitment – Mass Spectrometrist

MASS SPECTROMETRIST – BIOMARKER VERIFICATION AND VALIDATION   Project/Job Description Metabolomic Diagnostics Ltd is an early stage biotechnology company located in Cork, Ireland. The company is developing novel and innovative tests to predict pregnancy related complications prior to their clinical manifestation. The technology is based [...]

European Funding for Novel Technology

Irish SME wins EU funding for novel test to detect preeclampsia.

Load More Posts